Immune Checkpoint Inhibitors in Gliomas, Curr. Oncol. Rep, vol.19, p.23, 2017. ,
Advances and challenges: dendritic cell vaccination strategies for glioblastoma, Expert Rev. Vaccines, vol.16, pp.27-36, 2017. ,
Oncolytic Viruses: Treatment and Implications for Patients With Gliomas, Clin. J. Oncol. Nurs, vol.21, issue.2, pp.60-64, 2017. ,
Specific Inhibition of DNMT3A/ISGF3g Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth, Theranostics, vol.6, pp.1988-1999, 2016. ,
Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness, Epigenomics, vol.6, pp.267-275, 2014. ,
Specific inhibition of one DNMT1-including complex influences tumor initiation and progression, Clin. Epigenetics, vol.5, p.9, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00851207
MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review, Crit. Rev. Oncol. Hematol, vol.120, pp.22-33, 2017. ,
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics, Cancer Med, vol.5, pp.1917-1946, 2016. ,
miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks, Oncotarget, vol.6, pp.38628-38642, 2015. ,
MicroRNAs as Multifaceted Players in Glioblastoma Multiforme, Int. Rev. Cell Mol. Biol, vol.333, pp.269-323, 2017. ,
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression, Sci. Rep, vol.6, p.32972, 2016. ,
MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme, Cell Death Dis, vol.3, p.398, 2012. ,
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature, Mol. Oncol, vol.9, pp.704-714, 2015. ,
Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma, J. Exp. Clin. Cancer Res, vol.33, p.9, 2014. ,
MiR-370 functions as prognostic marker in patients with hepatocellular carcinoma, Eur. Rev. Med. Pharmacol. Sci, vol.21, pp.3581-3585, 2017. ,
Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia, Int. J. Clin. Exp. Pathol, vol.8, pp.14658-14666, 2015. ,
Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease, Biomed. Rep, vol.5, pp.332-336, 2016. ,
Plasma levels of lipometabolismrelated miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease, Lipids Health Dis, vol.11, p.55, 2012. ,
MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression, Oncotarget, vol.8, pp.88139-88151, 2017. ,
The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia, Mol. Cancer, vol.11, p.56, 2012. ,
miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC), Biomed. Pharmacother, vol.68, pp.149-154, 2014. ,
Overexpression of miR-370 and downregulation of its novel target TGFb-RII contribute to the progression of gastric carcinoma, Oncogene, vol.31, pp.226-237, 2012. ,
MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B, Biomed. Pharmacother, vol.90, pp.278-286, 2017. ,
FoxM1: Repurposing an oncogene as a biomarker, Semin. Cancer Biol, vol.52, pp.74-84, 2017. ,
Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1, Mol. Carcinog, vol.29, pp.112-126, 2000. ,
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished, J. Virol, vol.76, pp.2753-2762, 2002. ,